Clinical Trial Update: Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing

View source ↗

Summary

A completed clinical trial evaluating daytime versus nighttime dosing of an antimuscarinic treatment for female patients with Overactive Bladder Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder Syndrome

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Overactive Bladder Syndrome | Status: COMPLETED